Want to see HK:1312 full AI Analyst Report?
Kontafarma China Holdings Ltd (1312) Ratios
Kontafarma China Holdings Ltd Ratios
HK:1312's free cash flow for Q2 2026 was $1.79M. For the 2026 fiscal year, HK:1312's free cash flow was decreased by $-9.32M and operating cash flow was $11.11M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.79 | 1.26 | 1.53 | 1.37 | 1.11 |
| Quick Ratio | 0.59 | 1.06 | 1.28 | 1.14 | 0.93 |
| Cash Ratio | 0.14 | 0.18 | 0.20 | 0.24 | 0.24 |
| Solvency Ratio | -0.57 | -0.05 | 0.12 | 0.08 | 0.10 |
| Operating Cash Flow Ratio | 0.17 | 0.11 | 0.10 | -0.00 | 0.11 |
| Short-Term Operating Cash Flow Coverage | 1.17 | 0.53 | 0.94 | -0.01 | 0.33 |
| Net Current Asset Value | $ -223.20M | $ -68.89M | $ -77.63M | $ -274.66M | $ -440.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.19 | 0.19 | 0.28 | 0.28 |
| Debt-to-Equity Ratio | 0.37 | 0.30 | 0.32 | 0.54 | 0.61 |
| Debt-to-Capital Ratio | 0.27 | 0.23 | 0.24 | 0.35 | 0.38 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.00 | 0.01 | 0.09 | 0.01 |
| Financial Leverage Ratio | 1.93 | 1.62 | 1.63 | 1.93 | 2.15 |
| Debt Service Coverage Ratio | -2.35 | -0.50 | 1.12 | 0.19 | 0.42 |
| Interest Coverage Ratio | -22.57 | -3.17 | -10.77 | -5.90 | -2.91 |
| Debt to Market Cap | 0.47 | 0.61 | 0.26 | 1.04 | 0.89 |
| Interest Debt Per Share | 0.04 | 0.06 | 0.06 | 0.11 | 0.14 |
| Net Debt to EBITDA | -0.91 | -4.34 | 3.26 | 17.38 | 5.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 56.15% | 57.51% | 58.25% | 56.62% | 49.32% |
| EBIT Margin | -26.55% | -10.30% | -3.54% | -10.57% | -2.60% |
| EBITDA Margin | -16.59% | -5.56% | 9.70% | 3.01% | 13.97% |
| Operating Profit Margin | -26.55% | -4.74% | -20.31% | -15.36% | -12.16% |
| Pretax Profit Margin | -49.71% | -10.92% | -5.43% | -13.17% | -6.78% |
| Net Profit Margin | -46.77% | -8.42% | -3.56% | -4.65% | -1.87% |
| Continuous Operations Profit Margin | -52.76% | -11.03% | -7.55% | -12.27% | -7.01% |
| Net Income Per EBT | 94.09% | 77.10% | 65.67% | 35.29% | 27.63% |
| EBT Per EBIT | 187.26% | 230.46% | 26.73% | 85.76% | 55.74% |
| Return on Assets (ROA) | -40.17% | -4.76% | -1.67% | -1.96% | -0.59% |
| Return on Equity (ROE) | -77.33% | -7.72% | -2.73% | -3.77% | -1.26% |
| Return on Capital Employed (ROCE) | -40.31% | -3.71% | -12.23% | -8.50% | -5.26% |
| Return on Invested Capital (ROIC) | -33.21% | -3.28% | -11.34% | -6.96% | -4.52% |
| Return on Tangible Assets | -51.52% | -6.80% | -2.36% | -2.91% | -0.85% |
| Earnings Yield | -264.46% | -52.08% | -14.36% | -16.55% | -5.50% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.64 | 8.26 | 2.22 | 2.32 | 1.97 |
| Payables Turnover | 50.43 | 57.27 | 50.62 | 18.13 | 12.18 |
| Inventory Turnover | 4.41 | 4.44 | 3.44 | 3.47 | 3.70 |
| Fixed Asset Turnover | 2.23 | 1.84 | 1.41 | 1.32 | 0.83 |
| Asset Turnover | 0.86 | 0.57 | 0.47 | 0.42 | 0.31 |
| Working Capital Turnover Ratio | 103.84 | 5.63 | 4.16 | 6.80 | 7.03 |
| Cash Conversion Cycle | 154.13 | 120.10 | 263.67 | 242.02 | 253.47 |
| Days of Sales Outstanding | 78.62 | 44.21 | 164.71 | 157.00 | 184.83 |
| Days of Inventory Outstanding | 82.75 | 82.27 | 106.17 | 105.16 | 98.61 |
| Days of Payables Outstanding | 7.24 | 6.37 | 7.21 | 20.14 | 29.97 |
| Operating Cycle | 161.37 | 126.48 | 270.88 | 262.16 | 283.44 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.01 | 0.01 | 0.01 | -0.00 | 0.01 |
| Free Cash Flow Per Share | 0.01 | 0.01 | 0.00 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 3.26 | 3.45 | 1.53 | -0.04 | 0.60 |
| Capital Expenditure Coverage Ratio | 3.26 | 3.45 | 1.53 | -0.04 | 0.60 |
| Operating Cash Flow Coverage Ratio | 0.38 | 0.16 | 0.11 | -0.00 | 0.10 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.05 | 0.05 | -0.00 | 0.09 |
| Free Cash Flow Yield | 32.86% | 23.03% | 6.43% | -21.45% | -18.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.38 | -1.92 | -6.96 | -6.04 | -18.17 |
| Price-to-Sales (P/S) Ratio | 0.18 | 0.16 | 0.25 | 0.28 | 0.34 |
| Price-to-Book (P/B) Ratio | 0.29 | 0.15 | 0.19 | 0.23 | 0.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 3.04 | 4.34 | 15.54 | -4.66 | -5.54 |
| Price-to-Operating Cash Flow Ratio | 2.11 | 3.08 | 5.41 | -115.95 | 3.64 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -0.01 | 0.23 | -0.03 | 0.19 |
| Enterprise Value Multiple | -1.97 | -7.24 | 5.82 | 26.71 | 7.44 |
| Enterprise Value | 299.40M | 361.65M | 457.01M | 719.17M | 834.35M |
| EV to EBITDA | -1.97 | -7.24 | 5.82 | 26.71 | 7.44 |
| EV to Sales | 0.33 | 0.40 | 0.56 | 0.80 | 1.04 |
| EV to Free Cash Flow | 5.63 | 10.83 | 35.36 | -13.36 | -16.92 |
| EV to Operating Cash Flow | 3.90 | 7.69 | 12.31 | -332.18 | 11.11 |
| Tangible Book Value Per Share | 0.04 | 0.09 | 0.10 | 0.08 | 0.10 |
| Shareholders’ Equity Per Share | 0.10 | 0.18 | 0.19 | 0.20 | 0.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.06 | -0.01 | -0.39 | 0.07 | -0.03 |
| Revenue Per Share | 0.16 | 0.16 | 0.15 | 0.16 | 0.14 |
| Net Income Per Share | -0.08 | -0.01 | -0.01 | -0.01 | -0.00 |
| Tax Burden | 0.94 | 0.77 | 0.66 | 0.35 | 0.28 |
| Interest Burden | 1.87 | 1.06 | 1.53 | 1.25 | 2.61 |
| Research & Development to Revenue | 0.01 | 0.04 | 0.03 | 0.03 | 0.06 |
| SG&A to Revenue | 0.60 | 0.58 | 0.14 | 0.13 | 0.17 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.17 | -0.48 | -0.85 | 0.05 | -230.27 |
Currency in HKD